IN2014CN03888A - - Google Patents

Download PDF

Info

Publication number
IN2014CN03888A
IN2014CN03888A IN3888CHN2014A IN2014CN03888A IN 2014CN03888 A IN2014CN03888 A IN 2014CN03888A IN 3888CHN2014 A IN3888CHN2014 A IN 3888CHN2014A IN 2014CN03888 A IN2014CN03888 A IN 2014CN03888A
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Michael Weiss
Original Assignee
Univ Case Western Reserve
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Case Western Reserve filed Critical Univ Case Western Reserve
Publication of IN2014CN03888A publication Critical patent/IN2014CN03888A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82Translation products from oncogenes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IN3888CHN2014 2011-10-27 2014-05-23 IN2014CN03888A (OSRAM)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161552246P 2011-10-27 2011-10-27
PCT/US2012/062423 WO2013063572A1 (en) 2011-10-27 2012-10-29 Ultra-concentrated rapid-acting insulin analogue formulations

Publications (1)

Publication Number Publication Date
IN2014CN03888A true IN2014CN03888A (OSRAM) 2015-10-16

Family

ID=48168643

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3888CHN2014 IN2014CN03888A (OSRAM) 2011-10-27 2014-05-23

Country Status (10)

Country Link
US (1) US9908925B2 (OSRAM)
EP (1) EP2771026A4 (OSRAM)
JP (1) JP2014533241A (OSRAM)
KR (1) KR20150021011A (OSRAM)
CN (1) CN104010652A (OSRAM)
AU (1) AU2012328407A1 (OSRAM)
BR (1) BR112014010139A2 (OSRAM)
IN (1) IN2014CN03888A (OSRAM)
SG (1) SG11201401835VA (OSRAM)
WO (1) WO2013063572A1 (OSRAM)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013337250B2 (en) * 2012-11-05 2017-06-22 Case Western Reserve University Long-acting single-chain insulin analogues
AU2015204491B2 (en) * 2014-01-13 2021-01-07 Thermalin Inc. Rapid action insulin formulations and pharmaceutical delivery systems
AR099569A1 (es) 2014-02-28 2016-08-03 Novo Nordisk As Derivados de insulina y los usos médicos de estos
CA2964918A1 (en) * 2014-10-20 2016-04-28 Case Western Reserve University Halogenated insulin analogues of enhanced biological potency
SG10201809457YA (en) * 2014-11-21 2018-11-29 Merck Sharp & Dohme Insulin receptor partial agonists
WO2016105545A2 (en) * 2014-12-24 2016-06-30 Case Western Reserve University Insulin analogues with enhanced stabilized and reduced mitogenicity
EP3341402A1 (en) 2015-08-25 2018-07-04 Novo Nordisk A/S Novel insulin derivatives and the medical uses hereof
WO2017032795A1 (en) 2015-08-25 2017-03-02 Novo Nordisk A/S Novel insulin derivatives and the medical uses hereof
ES2908373T3 (es) 2015-08-25 2022-04-28 Novo Nordisk As Nuevos derivados de insulina y los usos médicos de los mismos
WO2017070617A1 (en) * 2015-10-21 2017-04-27 Case Western Reserve University Diol-modified insulin analogues containing a glucose-regulated conformational switch
KR20180097517A (ko) 2015-12-23 2018-08-31 케이스 웨스턴 리저브 유니버시티 매우 안정된 인슐린 유사체의 중합체 용융물 내 캡슐화
CA3122636A1 (en) * 2018-12-11 2020-06-18 Sanofi Insulin analogs having reduced insulin receptor binding affinity
PE20221260A1 (es) 2019-12-11 2022-08-16 Novo Nordisk As Analogos de insulina novedosos y usos de estos
WO2024194897A1 (en) * 2023-03-22 2024-09-26 Council Of Scientific And Industrial Research An Indian Registered Body Incorporated Under The Regn. Of Soc. Act (Act Xxi Of 1860) A glycation resistant insulin polypeptide and a method of preparing the same thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992418A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin
KR900701842A (ko) 1988-07-20 1990-12-04 헨리 브뢰늄 인간 인슐린 동족체와 그를 포함하는 제제
US5474978A (en) 1994-06-16 1995-12-12 Eli Lilly And Company Insulin analog formulations
US20030104981A1 (en) * 1995-11-03 2003-06-05 Jelena Mandic Human insulin analogues
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
JP2005526009A (ja) 2001-12-02 2005-09-02 ノボ ノルディスク アクティーゼルスカブ 新規グルコース依存性インスリン
US7317000B2 (en) 2001-12-02 2008-01-08 Novo Nordisk A/S Glucose-dependent insulins
CA2522818A1 (en) * 2003-03-11 2004-09-23 Soren Ostergaard Pharmaceutical preparations comprising acid-stabilised insulin
SE0401942D0 (sv) 2004-07-28 2004-07-28 Lipopeptide Ab New antimicrobial peptide complexes
JP2008510692A (ja) * 2004-08-20 2008-04-10 ノボ ノルディスク アクティーゼルスカブ 薬学的に活性なインスリン受容体調節分子
ES2554773T3 (es) * 2006-10-04 2015-12-23 Case Western Reserve University Insulina y análogos de la insulina resistentes a la fibrilación
ES2632504T3 (es) 2007-11-20 2017-09-13 Ambrx, Inc. Polipéptidos de insulina modificados y sus usos
KR20120129875A (ko) 2008-07-31 2012-11-28 케이스 웨스턴 리저브 유니버시티 염소화 아미노산을 갖는 인슐린 유사체
MY158627A (en) * 2008-07-31 2016-10-31 Univ Case Western Reserve Halogen-stabilized insulin
CA2747490C (en) * 2008-12-19 2017-02-14 Indiana University Research And Technology Corporation Insulin analogs

Also Published As

Publication number Publication date
AU2012328407A1 (en) 2014-05-22
BR112014010139A2 (pt) 2017-04-25
US20140323398A1 (en) 2014-10-30
SG11201401835VA (en) 2014-09-26
CN104010652A (zh) 2014-08-27
NZ624493A (en) 2016-02-26
WO2013063572A1 (en) 2013-05-02
KR20150021011A (ko) 2015-02-27
EP2771026A1 (en) 2014-09-03
EP2771026A4 (en) 2015-08-05
JP2014533241A (ja) 2014-12-11
US9908925B2 (en) 2018-03-06

Similar Documents

Publication Publication Date Title
BR112013022641A2 (OSRAM)
BR112013031251A2 (OSRAM)
BR112013027245A2 (OSRAM)
BR112013024383A2 (OSRAM)
BR112013023185A2 (OSRAM)
BR112013026905A2 (OSRAM)
BR112013022995A2 (OSRAM)
BR112013017670A2 (OSRAM)
BR112013027830A2 (OSRAM)
AP3853A (OSRAM)
BR112013026744A2 (OSRAM)
BR112013023927A2 (OSRAM)
BR112013027452A2 (OSRAM)
BR112013024365A2 (OSRAM)
BR112013028733A2 (OSRAM)
BR112013027121A2 (OSRAM)
BR112013024588A2 (OSRAM)
BR112013031556A2 (OSRAM)
BR112013026790A2 (OSRAM)
BR112013032368A2 (OSRAM)
BR112013032377A2 (OSRAM)
BR112013032380A2 (OSRAM)
BR112013027836A2 (OSRAM)
BR112013018949A2 (OSRAM)
BR112013026895A2 (OSRAM)